Tyche Wealth Partners’s CRISPR Therapeutics CRSP Stock Holding History

Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
$768K Buy
15,785
+6,600
+72% +$321K 0.15% 103
2025
Q1
$313K Buy
9,185
+850
+10% +$28.9K 0.07% 190
2024
Q4
$328K Buy
+8,335
New +$328K 0.07% 203